Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Nucleic Acids Research
|
February 12, 1998
Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure
L Dassonneville, F Hamy, P Colson, et al.
The Biochemical Journal
|
May 15, 1994
Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin
C Bailly, D Gentle, F Hamy, et al.
Bioconjugate Chemistry
|
September 1, 1991
Nuclear targeting of a viral-cointernalized protein by a short signal sequence from human retinoic acid receptors
F Hamy, P Verwaerde, N Helbecque, et al.
HIV Medicine
|
January 26, 2008
Detection of drug-resistant HIV minorities in clinical specimens and therapy failure
S Louvel, M Battegay, P Vernazza, et al.
Prostate Cancer and Prostatic Diseases
|
March 29, 2003
Specific block of androgen receptor activity by antisense oligonucleotides
F Hamy, V Brondani, R Spoerri, et al.
Chemistry & Biology
|
September 12, 2000
Blocking HIV replication by targeting Tat protein
F Hamy, N Gelus, M Zeller, et al.
FEBS Letters
|
November 22, 2000
The chromosomal protein HMG-D binds to the TAR and RBE RNA of HIV-1
P B Arimondo, N Gelus, F Hamy, et al.
Biochemistry
|
May 16, 1998
A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition
F Hamy, V Brondani, A Flörsheimer, et al.
Biochemistry
|
July 7, 1999
The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles
C Bailly, C Carrasco, F Hamy, et al.
Bioorganic & Medicinal Chemistry
|
July 31, 1999
Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains
N Gelus, C Bailly, F Hamy, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Nucleic Acids Research
|
February 12, 1998
Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure
L Dassonneville, F Hamy, P Colson, et al.
The Biochemical Journal
|
May 15, 1994
Localized chemical reactivity in DNA associated with the sequence-specific bisintercalation of echinomycin
C Bailly, D Gentle, F Hamy, et al.
Bioconjugate Chemistry
|
September 1, 1991
Nuclear targeting of a viral-cointernalized protein by a short signal sequence from human retinoic acid receptors
F Hamy, P Verwaerde, N Helbecque, et al.
HIV Medicine
|
January 26, 2008
Detection of drug-resistant HIV minorities in clinical specimens and therapy failure
S Louvel, M Battegay, P Vernazza, et al.
Prostate Cancer and Prostatic Diseases
|
March 29, 2003
Specific block of androgen receptor activity by antisense oligonucleotides
F Hamy, V Brondani, R Spoerri, et al.
Chemistry & Biology
|
September 12, 2000
Blocking HIV replication by targeting Tat protein
F Hamy, N Gelus, M Zeller, et al.
FEBS Letters
|
November 22, 2000
The chromosomal protein HMG-D binds to the TAR and RBE RNA of HIV-1
P B Arimondo, N Gelus, F Hamy, et al.
Biochemistry
|
May 16, 1998
A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition
F Hamy, V Brondani, A Flörsheimer, et al.
Biochemistry
|
July 7, 1999
The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles
C Bailly, C Carrasco, F Hamy, et al.
Bioorganic & Medicinal Chemistry
|
July 31, 1999
Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains
N Gelus, C Bailly, F Hamy, et al.
Page
of 3